Results 21 to 30 of about 558,994 (238)
Toward Sustainable Healthcare: Examining ESG‐Readiness in Austrian Regional State‐Owned Hospitals
Sustainable Development, EarlyView.ABSTRACT Reporting on environmental, social, and governance (ESG) issues is now an essential part of responsible corporate governance, including in the healthcare sector. This study investigates the ESG reporting practices of Austrian regional state‐owned hospitals (rSOHs), contributing to the growing sustainability literature. Thirteen interviews with
Philumena Bauer +3 more
wiley +1 more source
Post operative analgesia after caesarean section: an experience with intrathecal buprenorphine
Indian Journal of Anaesthesia, 2007 Buprenorphine is a mixed agonist-antagonist narcotic with high affinity at both µ and k opiate receptors. The aim of the study was to compare intrathecal bupivacaine (0.5%) and buprenorphine (60µg) with bupivacaine (0.5%) for postoperative analgesia in ...
Sunil Dixit
doaj
The Hidden Costs of Coffee Production in the Eastern African Value Chains
Sustainable Development, EarlyView.ABSTRACT There is increasing recognition that significant hidden costs associated with agrifood systems are not reflected in market prices. Coffee is among the three most traded agricultural commodities in the world and supports the livelihoods of more than 30 million smallholder households.
Annet Adong +3 more
wiley +1 more source
Management of postoperative ileus: focus on alvimopan
Therapeutics and Clinical Risk Management, 2008 Eric L Marderstein, Conor P DelaneyDivision of Colorectal Surgery, Department of Surgery, University Hospitals Case Medical Center, Case Western, Reserve School of Medicine, Cleveland, Ohio, USAAbstract: Postoperative ileus (POI) is a transient loss of ...
Eric L Marderstein, Conor P Delaney
doaj
Interactions of narcotic antagonists and antagonist-analgesics
Journal of Pharmacy and Pharmacology, 1968 Abstract In the rat the potent narcotic antagonist N-cyclopropylmethyl-6,14-endoethano-7α- (1-hydroxy-1-methylethyl)-tetrahydronororipavine (M5050, Reckitt), which itself lacks analgesic activity, resembled naloxone in its capacity to reverse the antinociceptive effects of morphine antagonist-analgesics. The nociceptive stimulus employed
G F, Blane, D, Dugdall
openaire +2 more sources
The Chemical Record, EarlyView.This review highlights the characteristic odor markers of illicit drugs, emphasizing volatile markers from both natural and synthetic sources, and explores the shift from canine‐based detection to emerging noncontact sensing technologies. Illicit drug use remains a global concern, requiring effective detection methods to counter evolving concealment ...
Minwoo Kim +4 more
wiley +1 more source
Criminology, EarlyView.Abstract Discourse around drug policy presents a stark contrast between policing and harm reduction models, sparking debates on the state's regulatory versus protective role. Canada is an ideal case to study drug policy models due to its global recognition as a leader in harm reduction alongside continued reliance on policing of drugs.
Taylor Domingos
wiley +1 more source
Can enhanced street lighting improve public safety at scale?
Criminology &Public Policy, EarlyView.Abstract Research Summary Street crimes are thought to be influenced by changes in ambient lighting; yet, most studies have focused on small‐scale interventions in limited areas. It remains unclear whether enhanced lighting can improve safety on a larger, jurisdiction‐wide scale.
John M. MacDonald +6 more
wiley +1 more source
Drug use among people in prison: A global review of epidemiology, harms and interventions
Addiction, EarlyView.Abstract Background and aims People who use drugs are overrepresented in the criminal justice system. We aimed to provide a broad synthesis of the epidemiology, harms and interventions related to drug use and drug use disorders among incarcerated adults worldwide, and highlight gaps in evidence and practice.
Louis Favril, John Strang, Seena Fazel
wiley +1 more source
Addiction, EarlyView.Abstract Background and aims While the health hazards of synthetic cannabinoid receptor agonists (SCRAs) are often approximated using in vitro pharmacological parameters as surrogate, this approach fails to consider pharmacokinetic and pharmacodynamic complexity.
Michaela J. Sommer +3 more
wiley +1 more source